Thursday, 4 June 2020

Novavax gets U.S. defense funding for its COVID-19 vaccine

The announcement of Novavax's vaccine trial came last month as drugmakers pause clinical trials on drugs for other ailments to focus on COVID-19, the illness caused by the novel coronavirus that has resulted in more than 386,379 deaths globally.

from The Hindu - Home https://ift.tt/2MvZXe2
via IFTTT

No comments:

Post a Comment